Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Awad D, Cao PH, Pulliam TL, Spradlin M, Subramani E, Tellman TV, et al. Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity. Cancer Res. 2024;84(5):703-724.

Kinoshita H, Martinez-Ordoñez A, Cid-Diaz T, Han Q, Duran A, Muta Y, et al. Epithelial aPKC deficiency leads to stem cell loss preceding metaplasia in colorectal cancer initiation. Dev Cell. 2024;59(15):1972-1987.e8.

Cung M, Sosa B, Yang HS, McDonald MM, Matthews BG, Vlug AG, et al. The performance of artificial intelligence chatbot large language models to address skeletal biology and bone health queries. J Bone Miner Res. 2024.

Thomson AL, Suhardi VJ, Niu Y, Oktarina A, Döring K, Chao C, et al. A translational murine model of aseptic loosening with osseointegration failure. J Orthop Res. 2024;42(11):2525-2534.

Li J, Chin CR, Ying H-, Meydan C, Teater MR, Xia M, et al. Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment. Nat Commun. 2024;15(1):2879.

Lee-Saxton YJ, Egan CE, Bratton BA, Thiesmeyer JW, Greenberg JA, Marshall TE, et al. Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence. J Clin Endocrinol Metab. 2024.

Khanjar B, Sejdiu Z, Mitre M, Mancebo S, Magro C, Harp J. Enfortumab vedotin toxic epidermal necrolysis-like blistering dermatosis: A case series and review of the literature. JAAD Case Rep. 2024;43:40-50.

Chan AT, Maya TR, Park C, Tak K, Liberman N, Jain RH, et al. Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses. JACC Cardiovasc Imaging. 2024;17(2):128-145.

Ntiri M, Nazarian A, Magro C, Alexis AF. Nodular (keloidal) scleroderma: A case series of 5 patients. JAAD Case Rep. 2024;49:135-139.

Pakula H, Omar M, Carelli R, Pederzoli F, Fanelli GN, Pannellini T, et al. Distinct mesenchymal cell states mediate prostate cancer progression. Nat Commun. 2024;15(1):363.